Literature DB >> 32436680

Accountable care organizations are increasingly led by physician groups rather than hospital systems.

David Muhlestein1, Tianna Tu, Carrie H Colla.   

Abstract

Because hospitals and health systems sponsored the majority of new accountable care organizations (ACOs) from 2010 to 2015, they influenced priorities and strategies of the policies designed to drive ACO adoption. In recent years, however, the majority of new ACOs have been sponsored by physician groups. This shift means that policies need to be developed with the characteristic strengths and weaknesses of physician-led ACOs in mind. Using data from the Leavitt Partners ACO database, we analyzed the types of providers becoming ACOs over time to look at their numbers and market potential. Because the market potential for further growth of physician group-led ACOs is much stronger than for hospital- or health system-led ACOs, policy makers need to create programs and policies that facilitate physician-led ACOs' success by helping them develop the capacity to take on risk, finance investments in high-value healthcare, and partner with other organizations to provide the full spectrum of care.

Mesh:

Year:  2020        PMID: 32436680     DOI: 10.37765/ajmc.2020.43154

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  2 in total

1.  The Relationship Between Governing Board Composition and Medicare Shared Savings Program Accountable Care Organizations Outcomes: an Observational Study.

Authors:  Kimberly E Reimold; Mohammad Kamal Faridi; Penelope S Pekow; Joshua Erban; Colin Flannelly; Ysabella Luikart; Peter K Lindenauer; Christene DeJong; Tom D'Aunno; Tara Lagu
Journal:  J Gen Intern Med       Date:  2021-09-01       Impact factor: 6.473

2.  Implementing accountable care organizations with integrative medicine in Korean health care system.

Authors:  Bo-Young Youn; Bo-Hyoung Jang; Chunhoo Cheon; Seong-Gyu Ko
Journal:  Integr Med Res       Date:  2020-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.